Glycominds Company

Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.
Technology: Biotechnology, Health Diagnostics
Industry: Personalized Medicine
Headquarters: Modi'in-Maccabim-Re'ut, Israel
Founded Date: 1999
Employees Number: 2 - 10
Funding Status: N/A

Visit Website
Register and Claim Ownership